ZA
CLX icon

Zweig Advisers’s Clorox CLX Stock Holding History

Zweig Advisers’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-60,000
Closed -$7.86M – 12
2016
Q2 		$7.86M Buy
+60,000
New +$7.78M 1.34% 30
2015
Q3 		– Sell
-65,000
Closed -$6.76M – 69
2015
Q2 		$6.76M Buy
+65,000
New +$7.01M 1.03% 51

Other funds holding CLX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CRC
Cedar Rock Capital London, United Kingdom $4.05B AUM 21.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return
AI
Analytic Investors Los Angeles, California $8.93B AUM 13.54% 1-Year Est. Return

Zweig Advisers's CLX Position: Q3 2016 in Review

Zweig Advisers sold out of Clorox (CLX) in Q3 2016, closing a stake of 60,000 shares — an estimated $7.86M sold.

Zweig Advisers first reported a position in CLX in Q2 2015 and held it in 2 quarters. The position peaked at $7.86M in Q2 2016. 823 funds tracked by Wall St. Rank hold CLX as of Q3 2016.

  • Zweig Advisers reported no remaining Clorox position as of Q3 2016 after selling out during the quarter.
  • Zweig Advisers sold 60,000 Clorox shares in Q3 2016, an estimated $7.86M.
  • Zweig Advisers first reported a position in Clorox in Q2 2015 and held it in 2 quarters.
  • Zweig Advisers's Clorox position peaked at $7.86M in Q2 2016.
  • 823 funds tracked by Wall St. Rank held Clorox as of Q3 2016.

Based on Zweig Advisers's 13F filing for Q3 2016.